Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (101-110 of 451) with videos related to

Pageof 46
Sort By:
Circulation. Arrhythmia and Electrophysiology|October 4, 2014
Response to Pasquale Santangeli, MD, Luigi Di Biase, MD, PhD, Andrea Natale, MDColleen M Hanley, Douglas Esberg, Peter R Kowey
Journal of Cardiovascular Electrophysiology|September 13, 2014
Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxisAlex B Garton, John Dudzinski, Peter R Kowey
Heart Rhythm|January 26, 2021
Corroboration equals collaborationVictoria M Robinson, Munveer Thind, Peter R Kowey
Cardiology|March 20, 2010
Born to be bradycardic?Jiangfang Lian, Gan-Xin Yan, Peter R Kowey
Cardiovascular Clinics|January 1, 1985
Electrophysiologic studies of the ventricleT R Engel, P R Kowey, L Wetstein
Heart Failure Clinics|March 13, 2016
Antiarrhythmic Drug Therapy for Atrial FibrillationMuhammad Rizwan Sardar, Wajeeha Saeed, Peter R Kowey
Progress in Cardiovascular Diseases|December 9, 2004
The clinical use of angiotensin-converting enzyme inhibitorsJoseph Wong, Rajiv A Patel, Peter R Kowey
Cardiovascular Research|February 1, 1983
Decreased vulnerability to ventricular fibrillation by vasodilator-induced baroreceptor sensitisationP R Kowey, R L Verrier, B Lown
American Heart Journal|December 1, 1983
The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia in the canine heartP R Kowey, R L Verrier, B Lown
Circulation. Arrhythmia and Electrophysiology|August 21, 2014
Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: conColleen M Hanley, Douglas Esberg, Peter R Kowey
Pageof 46

Showing results (101-110 of 451) with videos related to

Sort By:
Pageof 46
Circulation. Arrhythmia and Electrophysiology|October 4, 2014
Response to Pasquale Santangeli, MD, Luigi Di Biase, MD, PhD, Andrea Natale, MDColleen M Hanley, Douglas Esberg, Peter R Kowey
Journal of Cardiovascular Electrophysiology|September 13, 2014
Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxisAlex B Garton, John Dudzinski, Peter R Kowey
Heart Rhythm|January 26, 2021
Corroboration equals collaborationVictoria M Robinson, Munveer Thind, Peter R Kowey
Cardiology|March 20, 2010
Born to be bradycardic?Jiangfang Lian, Gan-Xin Yan, Peter R Kowey
Cardiovascular Clinics|January 1, 1985
Electrophysiologic studies of the ventricleT R Engel, P R Kowey, L Wetstein
Heart Failure Clinics|March 13, 2016
Antiarrhythmic Drug Therapy for Atrial FibrillationMuhammad Rizwan Sardar, Wajeeha Saeed, Peter R Kowey
Progress in Cardiovascular Diseases|December 9, 2004
The clinical use of angiotensin-converting enzyme inhibitorsJoseph Wong, Rajiv A Patel, Peter R Kowey
Cardiovascular Research|February 1, 1983
Decreased vulnerability to ventricular fibrillation by vasodilator-induced baroreceptor sensitisationP R Kowey, R L Verrier, B Lown
American Heart Journal|December 1, 1983
The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia in the canine heartP R Kowey, R L Verrier, B Lown
Circulation. Arrhythmia and Electrophysiology|August 21, 2014
Ablation versus drugs: what is the best first-line therapy for paroxysmal atrial fibrillation? Antiarrhythmic drugs are outmoded and catheter ablation should be the first-line option for all patients with paroxysmal atrial fibrillation: conColleen M Hanley, Douglas Esberg, Peter R Kowey
Pageof 46